Abstract |
Ascofuranone, an isoprenoid antibiotic initially purified from a culture broth of Ascochyta viciae, has multiple anticancer effects. However, the impacts of ascofuranone on the epithelial-mesenchymal transition (EMT) and epidermal growth factor ( EGF)-induced effects on human lung cancer cell lines have not been previously reported. Here, we show that ascofuranone exerts its anticancer effects by inhibiting the EGF-induced EMT and cell migration in human lung cancer cell lines. Ascofuranone significantly inhibited EGF-induced migration and invasion by lung cancer cells, and suppressed EGF-induced morphologic changes by regulating the expression of EMT-associated proteins. In addition, ascofuranone upregulated E-cadherin, and downregulated fibronectin, vimentin, Slug, Snail, and Twist. Inhibition of ERK/AKT/mTOR promoted EGF-induced E-cadherin downregulation and inhibited EGF-induced vimentin upregulation in response to ascofuranone, implying that inhibition of the EGF-induced EMT by ascofuranone was mediated by the ERK and AKT/mTOR pathways. Inhibition of c-Myc suppressed EGF-induced vimentin upregulation, suggesting the involvement of c-Myc. Collectively, these findings suggest that ascofuranone inhibits tumor growth by blocking the EGF-induced EMT through a regulatory mechanism involving ERK, AKT/mTOR, and c-Myc in lung cancer cells.
|
Authors | Hyo-Weon Kim, Yun-Jeong Jeong, Soon-Kyung Hwang, Yoon-Yub Park, Yung Hyun Choi, Cheorl-Ho Kim, Junji Magae, Young-Chae Chang |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 880
Pg. 173199
(Aug 05 2020)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 32439259
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier B.V. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- MYC protein, human
- Proto-Oncogene Proteins c-myc
- Sesquiterpenes
- Epidermal Growth Factor
- MTOR protein, human
- Proto-Oncogene Proteins c-akt
- TOR Serine-Threonine Kinases
- Extracellular Signal-Regulated MAP Kinases
- ascofuranone
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Survival
(drug effects)
- Epidermal Growth Factor
(pharmacology)
- Epithelial-Mesenchymal Transition
(drug effects)
- Extracellular Signal-Regulated MAP Kinases
(metabolism)
- Humans
- Lung Neoplasms
(drug therapy, metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Proto-Oncogene Proteins c-myc
(metabolism)
- Sesquiterpenes
(pharmacology)
- TOR Serine-Threonine Kinases
(metabolism)
- Wound Healing
(drug effects)
|